Prof. Dr. med. Martin Bornhaeuser
Principal investigator
Department of Internal Medicine I
University Hospital Carl Gustav Carus
Technische Universität Dresden
Fetscherstraße 74
01307 Dresden
Germany
Ph.: +49-351-458 4704
Fax: +49-351-458 5362
martin.bornhaeuser@uniklinikum-dresden.de
Research topic(s):
Allogeneic stem cell transplantation, Cellular therapy, Adoptive immunotherapy, Cell biology of mesenchymal and hematopoietic stem cells, Targeted therapy.
Education:
1986-1993 Study of medicine, Kiel, Germany
1989-1991 Doctoral thesis
2001 Habilitation for Internal Medicine, Dresden, Germany
Carreer:
1993-1994 Fellowship, Hematology/Oncology, University Hospital, Tübingen, Germany
1994 Stem Cell Laboratory, Department for Pediatrics, Tübingen, Germany
1995-1998 Internship, University Hospital, Dresden, Germany
1999 Board Certification for Internal Medicine
2000 Board Certification for Hematology/Oncology
1998-2003 Senior physician
2004 Head of Stem Cell Transplant Program, University Hospital, Dresden, Germany
2004 Endowed C3-Professorship Stem Cell Transplantation, Dresden, Germany
2009 W3 professor for Translational Biomedical Research, CRTD
2011 W3 Professor for Hematology/Oncology, University Hospital, Dresden
Other Qualifications:
2002 Certified Member of the European Society for Medical Oncology
Selectet Publications:
Kräter M, Jacobi A, Otto O, Tietze S, Müller K, Poitz DM, Palm S, Zinna VM, Biehain U, Wobus M, Chavakis T, Werner C, Guck J and Bornhauser, M (2017): Bone marrow niche-mimetics modulate HSPC function via integrin signaling. Scientific Reports. doi:10.1038/s41598-017-02352-5
Stölzel F, Mohr B, Kramer M, Oelschlägel U, Bochtler T, Berdel WE, Kaufmann M, Baldus CD, Schäfer-Eckart K, Stuhlmann R, Einsele H, Krause SW, Serve H, Hänel M, Herbst R, Neubauer A, Sohlbach K, Mayer J, Middeke JM, Platzbecker U, Schaich M, Krämer A, Röllig C, Schetelig J, Bornhauser M, Ehninger G (2016): Karyotype complexity and prognosis in acute myeloid leukemia. Blood Cancer J. 6:e386.
Wobus M, Bornhauser M, Jacobi A, Krater M, Otto O, Ortlepp C, Guck J, Ehninger G, Thiede C, Oelschlägel U (2015): Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia. Oncotarget. 36, 38804-15
Bornhauser M, Kienast J, Trenschel R, Burchert A, Hegenbart U, Stadler M, Baurmann H, Schafer-Eckart K, Holler E, Kroger N, Schmid C, Einsele H, Kiehl MG, Hiddemann W, Schwerdtfeger R, Buchholz S, Dreger P, Neubauer A, Berdel WE, Ehninger G, Beelen DW, Schetelig J, Stelljes M (2012): Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Lancet Oncol. 13, 1035-1044.
Cornelissen JJ, Gratwohl A, Schlenk RF, Sierra J, Bornhauser M, Juliusson G, Racil Z, Rowe JM, Russell N, Mohty M, Lowenberg B, Socie G, Niederwieser D, Ossenkoppele GJ (2012): The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat. Rev. Clin. Oncol. 9, 579-590.
Bornhauser M, Thiede C, Platzbecker U, Kiani A, Oelschlaegel U, Babatz J, Lehmann D, Holig K, Radke J, Tuve S, Wermke M, Wehner R, Jahnisch H, Bachmann MP, Rieber EP, Schetelig J, Ehninger G, Schmitz M (2011): Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia. Blood 117, 7174-7184.
Bornhauser M, Aringer M, Thiede C (2010): Mixed lymphohematopoietic chimerism and response in Wegener’s granulomatosis. N. Engl. J. Med. 362, 2431-2432.
Bornhauser M, Illmer T, Oelschlaegel U, Schetelig J, Ordemann R, Schaich M, Hanel M, Schuler U, Thiede C, Kiani A, Platzbecker U, Ehninger G (2008): Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia. Clin. Cancer Res. 14, 5585-5593.